Td Private Client Wealth LLC Novo Nordisk A S Transaction History

Td Private Client Wealth LLC

  • $3.58 Trillion
  • Q4 2024

A detailed history of Td Private Client Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Td Private Client Wealth LLC holds 3,014 shares of NVO stock, worth $237,955. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,014
Previous 4,558 33.87%
Holding current value
$237,955
Previous $543 Million 52.23%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$85.0 - $120.04 $131,240 - $185,341
-1,544 Reduced 33.87%
3,014 $259 Million
Q3 2024

Nov 18, 2024
SELL
$119.07 - $145.42 $42,627 - $52,060
-358 Reduced 7.28%
4,558 $543 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $603,242 - $722,209
4,916 New
4,916 $702 Million
Q1 2024

Aug 16, 2024
SELL
$102.11 - $135.92 $624,402 - $831,150
-6,115 Reduced 46.08%
7,156 $919 Million
Q4 2023

Aug 16, 2024
SELL
$87.78 - $105.45 $266,148 - $319,724
-3,032 Reduced 18.6%
13,271 $1.37 Billion
Q3 2023

Aug 16, 2024
BUY
$90.94 - $199.54 $822,279 - $1.8 Million
9,042 Added 124.53%
16,303 $1.48 Billion
Q2 2023

Aug 16, 2024
BUY
$155.98 - $172.65 $516,449 - $571,644
3,311 Added 83.82%
7,261 $1.18 Billion
Q1 2023

Aug 16, 2024
SELL
$132.34 - $159.14 $127,972 - $153,888
-967 Reduced 19.67%
3,950 $629 Million
Q4 2022

Aug 16, 2024
SELL
$102.55 - $135.33 $14,664 - $19,352
-143 Reduced 2.83%
4,917 $665 Million
Q3 2022

Aug 16, 2024
SELL
$95.28 - $116.93 $5,716 - $7,015
-60 Reduced 1.17%
5,060 $504 Million
Q2 2022

Aug 16, 2024
BUY
$103.24 - $121.81 $250,150 - $295,145
2,423 Added 89.84%
5,120 $571 Million
Q1 2022

Aug 16, 2024
SELL
$93.1 - $112.54 $43,012 - $51,993
-462 Reduced 14.62%
2,697 $300 Million
Q4 2021

Aug 16, 2024
BUY
$95.88 - $117.08 $11,217 - $13,698
117 Added 3.85%
3,159 $354 Million
Q3 2021

Aug 16, 2024
SELL
$84.42 - $106.62 $158,203 - $199,805
-1,874 Reduced 38.12%
3,042 $292 Million
Q2 2021

Aug 16, 2024
SELL
$67.66 - $84.76 $12,923 - $16,189
-191 Reduced 8.71%
2,003 $168 Million
Q1 2021

Aug 16, 2024
SELL
$67.06 - $75.82 $23,471 - $26,536
-350 Reduced 13.76%
2,194 $148 Million
Q4 2020

Aug 16, 2024
SELL
$63.89 - $73.8 $120,815 - $139,555
-1,891 Reduced 42.64%
2,544 $178 Million
Q3 2020

Aug 16, 2024
SELL
$63.69 - $70.22 $47,831 - $52,735
-751 Reduced 14.48%
4,435 $308 Million
Q2 2020

Aug 16, 2024
SELL
$58.54 - $67.94 $182,352 - $211,633
-3,115 Reduced 37.53%
5,186 $340 Million
Q1 2020

Aug 16, 2024
BUY
$49.46 - $64.78 $96,249 - $126,061
1,946 Added 30.62%
8,301 $500 Million
Q4 2019

Aug 16, 2024
BUY
$49.86 - $58.26 $71,748 - $83,836
1,439 Added 29.27%
6,355 $368 Million

Others Institutions Holding NVO

# of Institutions
1,884
Shares Held
336M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $178B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email